Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler

Pharmaceutical Research

Volumn 30, Issue 2, 2013, Pages 458-477

  Kaialy, Waseem ^a,b   Nokhodchi, Ali ^a,c  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

aerosol; freeze dried mannitol; morphology; porosity; spray dried mannitol

Indexed keywords

DRUG CARRIER; MANNITOL; SALBUTAMOL SULFATE;

AEROSOL; ARTICLE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FRACTIONATION; FREEZE DRYING; IN VITRO STUDY; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; SPRAY DRYING; STRUCTURE ANALYSIS;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRY POWDER INHALERS; FREEZE DRYING; LUNG; MANNITOL; PARTICLE SIZE; POWDERS;

EID: 84873475700     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0892-4     Document Type: Article

References (41)

1. Blagden N, De Matas M, Gavan P, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev. 2007;59:617-30.
2. Aquino R, Prota L, Auriemma G, Santoro A, Mencherini T, Colombo G, Russo P. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells. Int J Pharm. 2012;426:100-7.
3. Kaialy W, Martin GP, Ticehurst MD, Momin MN, Nokhodchi A. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient. Int J Pharm. 2010;392:178-88.
4. Kaialy W, Momin MN, Ticehurst MD, Murphy J, Nokhodchi A. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler. Colloid Surf B. 2010;79:345-56.
5. Kaialy W, Martin GP, Ticehurst MD, Royall P, Mohammad MA, Murphy J, Nokhodchi A. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers. AAPS J. 2011;13:30-43.
6. Kaialy W, Ticehurst MD, Murphy J, Nokhodchi A. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol - acetone. J Pharm Sci. 2011;100:2665-84.
7. Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers. Colloid Surf B. 2012;89:29-39.
8. Nokhodchi A, Kaialy W, Ticehurst MD. The influence of particle physicochemical properties on delivery of drugs by dry powder inhalers to the lung. In: Popescu MA, editor. Drug delivery book. NY: Hauppauge: Nova; 2011. p. 1-50.
9. Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A. Influence of lactose carrier particle size on the aerosol performance of budesonide from a dry powder inhaler. Powder Technol. 2012;227:74-85.
10. Podczeck F. The relationship between physical properties of lactose monohydrate and the aerodynamic behaviour of adhered drug particles. Int J Pharm. 1998;160:119-30.
11. Steckel H, Markefka P, TeWierik H, Kammelar R. Effect of milling and sieving on functionality of dry powder inhalation products. Int J Pharm. 2006;309:51-9.
12. Dickhoff B, De Boer A, Lambregts D, Frijlink H. The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time. Eur J Pharm Biopharm. 2003;56:291-302.
13. Donovan MJ, Smyth HDC. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations. Int J Pharm. 2010;402:1-9.
14. Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A. Effect of carrier particle shape on dry powder inhaler performance. Int J Pharm. 2011;421:12-23.
15. Kaialy W, Larhrib H, Ticehurst MD, Nokhodchi A. Influence of batch cooling crystallization on mannitol physical properties and drug dispersion from dry powder inhalers. Cryst Growth Des. 2012;12:300-3017.
16. Le VNP, Thi THH, Robins E, Flament M. Dry powder inhalers: Study of the parameters influencing adhesion and dispersion of fluticasone propionate. AAPS PharmSciTech. 2012;13:477-84.
17. Traini D, Young PM, Thielmann F, Acharya M. The influence of lactose pseudopolymorphic form on salbutamol Sulfate-Lactose interactions in DPI formulations. Drug Dev Ind Pharm. 2008;34:992-1001.
18. Byron PR, Jashnam R. Efficiency of aerosolization from dry powder blends of terbutaline sulfate and lactose NF with different particle-size distributions. Pharm Res. 1990;7:881.
19. Donovan MJ, Kim SH, Raman V, Smyth HD. Dry powder inhaler device influence on carrier particle performance. J Pharm Sci. 2012;101:1097-107.
20. Shur J, Harris H, Jones MD, Kaerger JS, Price R. The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations. Pharm Res. 2008;25:1631-40.
21. Zeng XM, Martin GP, Marriott C, Pritchard J. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. J Pharm Sci. 2001;90:1424-34.
22. Schneid S, Riegger X, Gieseler H. Influence of common excipients on the crystalline modification of freeze-dried mannitol. Pharm Technol. 2008;3:32.
23. Takada A, Nail SL, Yonese M. Influence of ethanol on physical state of freeze-dried mannitol. Pharm Res. 2009;26:1112-20.
24. Hottot A, Nakagawa K, Andrieu J. Effect of ultrasound-controlled nucleation on structural and morphological properties of freeze-dried mannitol solutions. Chem Eng Res Design. 2008;86:193-200.
25. Kim AI, Akers MJ, Nail SL. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J Pharm Sci. 1998;87:931-5.
26. Kaialy W, Ticehurst MD, Nokhodchi A. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate. Int J Pharm. 2012;423:184-94.
27. Kaialy W, Larhrib H, Martin GP, Nokhodchi A. The effect of engineered mannitol-lactose mixture on dry powder inhaler performance. Pharm Res. 2012;29:2139-56.
28. Krumbein WC. Measurement and geological significance of shape and roundness of sedimentary particles. J Sediment Res. 1941;11:64-72.
29. Fronczek FR, Kamel HN, Slattery M. Three polymorphs (α, β, and δ) of D-mannitol at 100 K. Acta Crystallogr. 2003;59:567-70.
30. Hinds WC. Aerosol technology: properties, behavior and measurement of airborne particles. New York: Jennings: Wiley; 1982.
31. Edwards DA. Delivery of biological agents by aerosols. AIChE J. 2002;48:2-6.
32. Hickey AJ. Pharmaceutical inhalation aerosol technology. New York: Marcel Dekker; 2004.
33. Ho R, Wilson DA, Heng JYY. Crystal habits and the variation in surface energy heterogeneity. Cryst Growth Des. 2009;9:4907-11.
34. Burger A, Henck JO, Hetz S, Rollinger JM, Weissnicht AA, Stöttner H. Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol. J Pharm Sci. 2000;89:457-68.
35. Le VNP, Bierend H, Robins E, Steckel H, Flament MP. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate. Int J Pharm. 2011;422:75-82.
36. Ganderton D. The generation of respirable clouds from coarse powder aggregates. J Biopharm Sci. 1992;3:101-5.
37. Kassem NM, Ganderton D. The influence of carrier surface on the characteristics of inspirable powder aerosols. J Pharm Pharmacol. 1990;42(11).
38. Staniforth JN, Rees JE, Lai FK, Hersey JA. Interparticle forces in binary and ternary ordered powder mixes. J Pharm Pharmacol. 1982;34(3):141-5.
39. Le V, Robins E, Flament M. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations. Eur J Pharm Biopharm. 2012;80:596-603.
40. Dunbar CA, Hickey AJ, Holzner P. Dispersion and characterization of pharmaceutical dry powder aerosols. Kona. 1998;16:7-45.
41. Yu L, Mishra DS, Rigsbee DR. Determination of the glass properties of D-mannitol using sorbitol as an impurity. J Pharm Sci. 1998;87:774-7.